TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Derek O'Hagan
Head of Global Discovery Support & New Technologie at GSK Vaccines

Profile

I am currently a Senior Advisor in Technical R&D in GSK Vaccines, since 2018, and also a GSK Fellow, since 2019. Prior to this I was the Global Head of Discovery Support and New Technology in GSK Vaccines. Until 2015, I was the Global Head of Vaccine Chemistry and Formulation Research for Novartis Vaccines. I was part of the original Team that established the program on Self Amplifying RNA vaccines (SAM) in Novartis, Cambridge, which is now an active program in GSK. I served on the Board of Scientific Advisors for the Controlled Release Society and I am a Fellow of the American Association of Pharmaceutical Scientists.

Derek O'Hagan's Network

Agenda Sessions

  • Self Amplifying mRNA (SAM) Vaccines for Rapid Response

    , 17:00